HAIFA, Israel, May 9 -- The Technion - Israel Institute of Technology issued the following news:

* * *

Improving the Personalization of Immunotherapy Treatments

Researchers from the Ruth and Bruce Rappaport Faculty of Medicine have identified a genetic "fingerprint" that helps predict the effectiveness of these treatments

Considered to be one of the greatest revolutions in cancer treatment, immunotherapy enhances the immune system . . .

Click here for more information about our products